Caitlin John’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Caitlin John’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.92K	Hold	62	–	–	﹤0.01%	554
2025 Q4	$7.56K	Hold	62	–	–	0.01%	578
2025 Q3	$6.21K	Buy	+62	New	+$5.58K	﹤0.01%	565
2025 Q1	–	Sell	-62	Closed	-$5.58K	–	817
2024 Q4	$5.58K	Hold	62	–	–	﹤0.01%	552
2024 Q3	$6.2K	Hold	62	–	–	﹤0.01%	543
2024 Q2	$5.75K	Hold	62	–	–	﹤0.01%	537
2024 Q1	$5.88K	Hold	62	–	–	﹤0.01%	541
2023 Q4	$5.54K	Buy	+62	New	+$4.6K	﹤0.01%	533

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Caitlin John's XBI Position: Q1 2026 in Review

Caitlin John held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 62 shares worth $7.92K. The position accounts for ﹤0.01% of the portfolio, ranked #554.

Caitlin John first reported a position in XBI in Q4 2023 and has held it in 8 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Caitlin John held 62 shares of State Street SPDR S&P Biotech ETF worth $7.92K as of Q1 2026.
Caitlin John left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Caitlin John's portfolio in Q1 2026, its #554 holding.
Caitlin John first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 8 quarters since.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.